Results 141 to 150 of about 138,544 (375)

CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study

open access: yesAllergy, EarlyView.
This study investigated the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria. Therapeutic equivalence between CT‐P39 and ref‑OMA (300 mg) was demonstrated by the primary endpoint – confidence intervals of the treatment difference in mean change ...
Sarbjit S. Saini   +16 more
wiley   +1 more source

The Features of Anaphylaxis Cases Followed in the Pediatric Allergy Clinic

open access: yesGüncel Pediatri, 2017
Introduction: Anaphylaxis is a severe hypersensitivity reaction that can be life-threatening. The frequency of anaphylaxis varies among the societies.
Mahmut Doğru   +4 more
doaj   +1 more source

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines

open access: yesJournal of Allergy and Clinical Immunology, 2021
K. Risma   +7 more
semanticscholar   +1 more source

Allergic Reactivity and Memory Occur Independently of Sequential Switching Through IgG1

open access: yesAllergy, EarlyView.
Sequential switching through IgG1 is not required to produce IgE with sufficient allergen‐binding affinity to cause anaphylaxis against food allergens. Sequential switching through IgG1 does not confer a competitive advantage to become an IgE‐expressing cell.
Joshua F. E. Koenig   +11 more
wiley   +1 more source

Fractionated vaccination with mRNA COVID‐19 vaccine is safe for patients with polyethylene glycol allergy

open access: yesClinical and Translational Allergy, 2023
Charlotte G. Mortz   +6 more
doaj   +1 more source

Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers

open access: yesJournal of Asthma and Allergy, 2018
Anaphylaxis is the most serious of all allergic reactions and can be fatal. The diagnosis is frequently delayed, and misdiagnosis often occurs with asthma or urticaria. Biomarkers such as tryptase are not routinely checked, and appropriate treatment with
T. Jiménez-Rodriguez   +3 more
semanticscholar   +1 more source

Oral Immunotherapy in Peanut‐Allergic Adults Using Real‐World Materials

open access: yesAllergy, EarlyView.
In 21 adults initiated on peanut oral immunotherapy (OIT), 67% tolerated at least 1000 mg on exit DBPCFC. Decreases in SPT size and increases in peanut‐ and Ara h 2‐specific IgG occurred in OIT participants but not in mechanistic controls (n = 9). Improvements were seen in FAQLQ‐AF and food neophobia scores.
Hannah Hunter   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy